Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate
Maaike Everts(University of Groningen), Grietje Molema(University Medical Center Groningen), Barbro N. Melgert(University Medical Center Groningen), Dirk K. F. Meijer(University of Groningen), Sigrídur A. Ásgeirsdóttir, Marja J.A. van Luyn(University Medical Center Groningen), Robbert J. Kok(Utrecht University), Tom J. M. Moolenaar(Centre for Human Drug Research), Gerben A. Koning(Università Cattolica del Sacro Cuore)
Cited by 90
Related Papers
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences
|Blood|2013|495
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
|Cancer Research|2012|458
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396